Targeting Copper: A Therapeutic Strategy In Lymphoma
Non-Hodgkin lymphomas often arise at sites of chronic inflammation, exposing them to oxidative stress, or increased levels of reactive oxygen species (ROS). Increases in ROS are associated with tumor initiation, promotion and progression. Chronic exposure to ROS may promote the transformation of l...
Main Author: | Lee, Kristy |
---|---|
Other Authors: | Briehl, Margaret M. |
Language: | en |
Published: |
The University of Arizona.
2013
|
Subjects: | |
Online Access: | http://hdl.handle.net/10150/294030 |
Similar Items
-
EGFR Rearrangements as Oncogenic Drivers and Therapeutic Targets in Lung Cancer
by: Gallant, Jean-Nicolas
Published: (2017) -
Therapeutic potential of targeting the oncofetal antigen ROR1
by: Behzadi, Fernanda
Published: (2019) -
Replication Study: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
by: Fraser Aird, et al.
Published: (2017-01-01) -
Registered report: BET bromodomain inhibition as a therapeutic strategy to target c-Myc
by: Irawati Kandela, et al.
Published: (2015-06-01) -
Assessment of therapeutic targets in experimental models of Myc-induced lymphoma
by: Plym Forshell, Linus
Published: (2011)